{"name":"The Emmes Company, LLC","slug":"the-emmes-company-llc","ticker":"","exchange":"","domain":"theemmescompanyllc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxOeUphWFdPTHp2TTVsQllJRjJmUjQ3LW51TnA5V3l2TERVN3BrdENuMWNFZXlTUGNCU1g4a0ZkU2xlYUZGYVQ5ZDM3ckRaMjV2d2J5SGhVWEtNd05qTHJRdXhhMW5ISEhEQlZsc2VNaXZibm12cXNDV0NIUVdTUTBVMVBZM2M2WVNKaHJkNExhRUIzS0w4RHlVSF9nYUx4MDRidGkyR1psdTBEWU5YTHpF?oc=5","date":"2024-12-13","type":"pipeline","source":"24-7 Press Release Newswire","summary":"Shawntel M. Swannack Honored for Expertise in Health Care - 24-7 Press Release Newswire","headline":"Shawntel M. Swannack Honored for Expertise in Health Care - 24-7 Press Release Newswire","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-06-25","type":"trial","source":"ET HealthWorld","summary":"Emmes Group to conduct Phase III studies of ILiAD Biotechnologies pertussis vaccine candidate, BPZE1 - ET HealthWorld","headline":"Emmes Group to conduct Phase III studies of ILiAD Biotechnologies pertussis vaccine candidate, BPZE1","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-06-24","type":"trial","source":"Business Wire","summary":"ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Conduct Upcoming Phase III Clinical Trials of BPZE1, the Leading Next-Generation Pe","headline":"ILiAD Biotechnologies Announces Planned Collaboration with Emmes Group, a New Mountain Capital Portfolio Company, to Con","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-06-12","type":"trial","source":"ET HealthWorld","summary":"AI emerges as a game-changer for faster, smarter clinical trials - ET HealthWorld","headline":"AI emerges as a game-changer for faster, smarter clinical trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxObXc4Z3pTRUllN3BwZHFsS3c0M25VSXhSRG9VZkJxRHFxRWNWLVh1bTNwU3N3TzZFWDVPMkh0SUdnZGJtTFB5LWVlODN0aU9DaVhfYWE2UTRWWWlTUW9nS2gyVWR5dW9qajZRMVo2bFFyZUtoNklLZy1KQlFDUEtXZTgwQzdlZw?oc=5","date":"2024-03-12","type":"pipeline","source":"thekeyexecutives.com","summary":"Top 25 CEOs of New Jersey for 2024 - thekeyexecutives.com","headline":"Top 25 CEOs of New Jersey for 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigJBVV95cUxPdjVOUGkwN0JPTHJMR0E0Skg4RGo5bHFJb2M2MDlOYjl6ZVNMZm9yY29OM0tDSUJnUE0wQ0V3WGpnNHBlRXVoX2RaZzBKQS1uZ2dMUXF1VkV1OTZtaUswaVVWVEJ0dEtxUHRvb2VDb1VYU2ZySVZMR1ZybGVJMVRrekVGMHNnb3R1RjBPSGZWVVVqMldkMmhwb01MQkFLYndCTXRFUldGSF9lSFVuQUxBRUh6dTVIa2dzeFZudnBkT2tlMi1BNEt4T3F1T0RPcDVEZFJaSFVIRW5DcFRXQVk2dWI1QV9vYUVzd0JCb3ZVbVA2aHZzNnczcDFZbWNUSEtWeENSMmw5dkFUUQ?oc=5","date":"2024-01-09","type":"pipeline","source":"PR Newswire","summary":"Creation of the Emmes Group Will Advance Company's 47-year Legacy and Build Clinical Research Infrastructure for the Future - PR Newswire","headline":"Creation of the Emmes Group Will Advance Company's 47-year Legacy and Build Clinical Research Infrastructure for the Fut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNbGhfMFVnZWlydDdsVTRvbFNZb2l6SVNpa3BCODh1SXFyMHZHbWRTaGlEaTFFcFN0QVd2c3lzWlhua2szTUY0cTlDdEFTam1mTEJ3TFQ4c1dDdXhGdUlGT0puWW1yaXlKREFxaUlucVpTRjJFNm5UNWZaS3loQnpVb3ZyMUcxYzJLV2RNRjRkS2pJWDdfUzM0cDlZRl8?oc=5","date":"2024-01-09","type":"pipeline","source":"Contract Pharma","summary":"Emmes Group to Build Clinical Research Infrastructure - Contract Pharma","headline":"Emmes Group to Build Clinical Research Infrastructure","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE1WQ3Q3bXFwYXpKZjV4bExTNm5XVTA0NVJheFF2SmNJVnZkXzFhaUhRN2gwd3Vtd1dkNW15Nmg5OVNFMndnMFI0Qi1UQUw3ODdiMGFhSVhvNkNYYWxqMGE2c0p0Wl9QbnRYUXJiZTJiVUtaODhqSXc?oc=5","date":"2022-09-26","type":"trial","source":"Straits Research","summary":"Pediatric Clinical Trials Market Size, Share & Trends By 2033 - Straits Research","headline":"Pediatric Clinical Trials Market Size, Share & Trends By 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPQ0hwZlhKOWEtR3BHQVlKWTNNZDV1ZmVBU2VSVjhtTTlCMUpvcFBqMDh3WGF6Wl9VVFdtTk41ZkF2VE4yNFJnNDdXV25nSER2bE1UdHJOLUFOUXMxVVU5TTlqTXpUTWI0QWdkM1ZETjZrMG1nTUVTMWtrOE1tZS1GaS1QTGw3eXU0ZllZY2E0RQ?oc=5","date":"2022-01-04","type":"deal","source":"Contract Pharma","summary":"Emmes Acquires CRO Institut Dr. Schauerte - Contract Pharma","headline":"Emmes Acquires CRO Institut Dr. Schauerte","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}